may mask emetic signs of disease, lowered seizure threshold, rash, skin pigmentation, anticholinergic effects, insomnia, extrapyramidal reactions, neuroleptic malignant syndrome. <6months ...

Cardiovascular disease. Hepatic impairment ... See Contraindications. Increased extrapyramidal effects with MAOIs. Avoid use with concomitant respiratory and CNS depressants (eg, alcohol ...